Heron Therapeutics EVP converts 11,770 stock units

Q: How many HRTX RSUs did William P. Forbes convert?

William P. Forbes converted 11,770 RSUs on October 30, 2026, and 11,695 RSUs on October 31, 2026, into common shares.

The RSUs were scheduled to vest in 16 installments, beginning one quarter after each grant date.

Available on EDGAR 11/03/2026 - 12:53 PM EST Accepted by SEC EDGAR 11/03/2026 - 12:53 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Heron Therapeutics, Inc. EVP, Chief Development Officer William P. Forbes reported converting 11,770 restricted stock units into common shares on October 30, 2026, and 11,695 units on October 31, 2026. On those dates, 3,349 and 3,327 shares, respectively, were delivered or withheld for payment of exercise price or tax liability, at a reported $0.28 per share. No Rule 10b5-1 plan was reported.

Insider Trade Summary

23,465 shares exercised/converted

Exercise 6 txns

Insider Forbes William P

Role EVP, Chief Development Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units ^F3	11,695	$0.00	$0.00
Exercise	Common Stock ^F1	11,695	--	--
Exercise Price or Tax Liability	Common Stock	3,327	$0.28	$931.56
Exercise	Restricted Stock Units ^F2	11,770	$0.00	$0.00
Exercise	Common Stock ^F1	11,770	--	--
Exercise Price or Tax Liability	Common Stock	3,349	$0.28	$937.72

Holdings After Transaction: Restricted Stock Units — 258,255 contracts (Direct); Common Stock — 260,734 shares (Direct)

Holdings Before and After: Restricted Stock Units, 281,720 to 258,255 contracts (Direct); Common Stock, 243,945 to 260,734 shares (Direct)

Footnotes (3)

F1. Each restricted stock unit represents a contingent right to receive one share of common stock.
F2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.
F3. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Key Figures

Restricted stock units converted: 11,770 shares Restricted stock units converted: 11,695 shares Shares delivered or withheld for payment of exercise price or tax liability: 3,349 shares +2 more

5 metrics

Restricted stock units converted 11,770 shares October 30, 2026

Restricted stock units converted 11,695 shares October 31, 2026

Shares delivered or withheld for payment of exercise price or tax liability 3,349 shares October 30, 2026

Shares delivered or withheld for payment of exercise price or tax liability 3,327 shares October 31, 2026

Reported per-share amount $0.28 per share Shares delivered or withheld for payment of exercise price or tax liability

Key Terms

Restricted Stock Units, contingent right, time-based vesting schedule

3 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share of common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"a contingent right to receive one share of common stock"

time-based vesting schedule financial

"vest upon the following time-based vesting schedule"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HRTX RSUs did William P. Forbes convert?

William P. Forbes converted 11,770 RSUs on October 30, 2026, and 11,695 RSUs on October 31, 2026, into common shares.

What was the vesting schedule for William P. Forbes's HRTX RSUs?

The RSUs granted January 30, 2026 were scheduled to vest in 16 equal quarterly installments, beginning one quarter after the grant date. The RSUs granted January 31, 2025 vest in 16 equal installments, beginning one quarter after the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forbes William P

(Last)

(First)

(Middle)

25 FENTON MAIN STREET

SUITE 300

(Street)

CARY

NORTH CAROLINA

27511

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HERON THERAPEUTICS, INC. /DE/ [ HRTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Development Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/30/2026		M		11,770	A	⁽¹⁾	255,715	D
Common Stock	10/30/2026		F		3,349	D	$0.28	252,366	D
Common Stock	10/31/2026		M		11,695	A	⁽¹⁾	264,061	D
Common Stock	10/31/2026		F		3,327	D	$0.28	260,734	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	$0	10/30/2026		M			11,770	⁽²⁾	⁽²⁾	Common Stock	11,770	$0	153,006	D
Restricted Stock Units	$0	10/31/2026		M			11,695	⁽³⁾	⁽³⁾	Common Stock	11,695	$0	105,249	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of common stock.

2. On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 188,315 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant.

3. The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

	/s/Kathryn Lester Attorney-in-fact for William P. Forbes	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR